Armstrong Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Armstrong Advisory Group's PFE Position: Q3 2026 in Review
Armstrong Advisory Group increased its Pfizer (PFE) stake by 0.4% in Q3 2026, buying an estimated $1.12K and bringing the position to 10,442 shares worth $298K. The position accounts for 0.02% of the portfolio, ranked #196.
Armstrong Advisory Group first reported a position in PFE in Q4 2022 and has held it in 16 quarters since. The position peaked at $449K in Q4 2022. 559 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Armstrong Advisory Group held 10,442 shares of Pfizer worth $298K as of Q3 2026.
- Armstrong Advisory Group bought 42 Pfizer shares in Q3 2026, an estimated $1.12K.
- Pfizer made up 0.02% of Armstrong Advisory Group's portfolio in Q3 2026, its #196 holding.
- Armstrong Advisory Group first reported a position in Pfizer in Q4 2022 and has held it in 16 quarters since.
- Armstrong Advisory Group's Pfizer position peaked at $449K in Q4 2022.
- 559 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.